₹3.50 to ₹45.50: Penny inventory turns multibagger. Rises 1200% in seven years

Must read

Abhishek Mukherjee
Abhishek Mukherjeehttps://www.hospitalitycareerprofile.com/
Abhishek Mukherjee is a seasoned market analyst with a deep understanding of financial trends and economic shifts. With years of experience in the field, Abhishek brings insightful analysis and up-to-date market news to help readers stay informed. His expertise spans stock markets, financial forecasts, and economic policy changes, making him a trusted voice in the industry.
- Advertisement -

Indrayani Biotech share worth gained over 2% on Wednesday, bouncing again from an over 4% fall within the earlier session. Indrayani Biotech shares have risen in seven of the final eight periods.

Indrayani Biotech inventory worth has rallied over 10% in a single week, however has fallen over 17% in three months and practically 30% year-to-date (YTD). Nevertheless, penny inventory has given multibagger returns over the long run.

- Advertisement -

Up to now 5 years, Indrayani Biotech shares have jumped 851%, whereas the penny inventory is up 1,200% in seven years.

On BSE, Indrayani Biotech inventory hit a 52-week excessive of 99.70 apiece on January 20, and a 52-week low of 35.00 on October 28.

Not too long ago, inventory exchanges sought clarification from the corporate on the share worth motion. The corporate mentioned it had been disclosing all the fabric occasions, data, bulletins occasionally that will have bearing on the operations/efficiency of the Firm, together with any worth delicate data, as required by the SEBI regulation.

- Advertisement -

“We want to additional make clear that there is no such thing as a pending materials data/announcement to be made as of date which have a bearing on the worth/quantity motion of the Firm or which requires disclosures in accordance with the regulatory necessities. We assume that the motion within the share worth of the Firm is only market pushed and the Firm has no function to play on this regard,” Indrayani Biotech mentioned in a BSE submitting on November 5.

Indrayani Biotech Q1 Outcomes

Indrayani Biotech reported web gross sales of 31.53 crore within the quarter ended June 2024, registering a fall of 25.49% from 42.31 crore in the identical quarter final 12 months. The corporate’s web revenue in Q1FY25 jumped to 0.85 crore from 0.21 crore, year-on-year (YoY).

At 12:40 PM, Indrayani Biotech shares have been buying and selling 1.57% increased at 45.37 apiece on the BSE. 

- Advertisement -
- Advertisement -

More articles

Latest article

spot_imgspot_imgspot_imgspot_img